FMGE medicine & allied subjects questions

The revised Jones criteria require either two major criteria, or one major plus two minor criteria, together with evidence of a preceding group A streptococcal infection, to diagnose acute rheumatic fever. This patient has two major criteria, polyarthritis and subcutaneous nodules (carditis is also suggested by the murmur and tachycardia), along with a history of sore throat and elevated ASO titer confirming prior streptococcal infection. Minor criteria include fever, arthralgia, elevated ESR/CRP, and prolonged PR interval, but major criteria take precedence when present. This case clearly has two major manifestations, so the diagnosis is secured without needing minor criteria.

• B. Minor criteria alone, without evidence of streptococcal infection, are never sufficient for diagnosis.
• C. Two minor criteria alone are insufficient; at least one major criterion or two major criteria are required.
• D. This combination would be sufficient but is not what this patient has, since two major criteria are already present.

Rheumatic heart disease remains the most common cause of mitral stenosis worldwide and especially in India, resulting from autoimmune damage to the mitral valve following group A streptococcal pharyngitis. The valve leaflets become thickened and fused at the commissures, producing the classic mid-diastolic murmur with presystolic accentuation described. The earliest symptom of mitral stenosis is exertional dyspnea due to elevated left atrial pressure transmitted to the pulmonary circulation. A history of childhood joint pains supports prior rheumatic fever as the etiology in this patient.

• A. Degenerative calcific mitral stenosis occurs in the elderly and is far less common than rheumatic disease.
• B. Congenital mitral stenosis is rare and usually presents in infancy or early childhood.
• D. Infective endocarditis typically causes valve regurgitation rather than stenosis.

ST elevation in leads II, III, and aVF corresponds to the inferior wall of the left ventricle, which is most commonly supplied by the right coronary artery. These three leads reflect electrical activity from the inferior surface of the heart, and concordant ST elevation in them is the classic pattern of inferior wall myocardial infarction. Right-sided leads should be checked in such patients to detect right ventricular involvement, since right coronary artery occlusion can also compromise right ventricular perfusion. Recognizing this lead distribution helps predict complications such as bradyarrhythmias from AV nodal ischemia.

• B. Anterior wall infarction shows ST elevation in leads V1 to V4, not II, III, aVF.
• C. Posterior wall infarction shows ST depression in V1-V3 with tall R waves, not elevation in the inferior leads.
• D. Lateral wall infarction shows ST elevation in leads I, aVL, V5, and V6.

Furosemide is a loop diuretic that acts on the thick ascending limb of the loop of Henle by inhibiting the Na-K-2Cl cotransporter on the luminal membrane. This blocks reabsorption of sodium, potassium, and chloride, abolishing the medullary concentration gradient and producing a potent natriuresis and diuresis. Because the loop of Henle normally reabsorbs about 25 percent of filtered sodium, loop diuretics are the most powerful class, making them first-line for relieving volume overload in heart failure. This rapid reduction in preload explains the quick symptomatic improvement in breathlessness and edema seen with furosemide.

• A. This describes potassium-sparing diuretics like amiloride, which have weak diuretic effect.
• B. This describes acetazolamide, which is a weak diuretic used mainly for glaucoma and altitude sickness.
• C. This describes thiazide diuretics, which are less potent and used mainly for hypertension, not acute volume overload.

Viridans group streptococci, particularly Streptococcus sanguinis and Streptococcus mutans, are the most common cause of subacute native valve endocarditis, especially in patients with pre-existing valve abnormalities such as a bicuspid aortic valve or rheumatic valve disease. These organisms are part of the normal oral flora and gain entry to the bloodstream following dental procedures or poor oral hygiene, then adhere to previously damaged endocardium. The subacute course over weeks, with low-grade fever, Osler nodes, and splinter hemorrhages, is typical of viridans streptococcal endocarditis rather than the acute fulminant course seen with more virulent organisms. This organism profile guides empirical antibiotic choice pending culture confirmation.

• A. Staphylococcus aureus causes acute, fulminant endocarditis and is more typical in intravenous drug users or prosthetic valves.
• B. Enterococcus faecalis is associated with endocarditis following genitourinary or gastrointestinal procedures, less common overall.
• D. Coagulase-negative staphylococci, such as Staphylococcus epidermidis, are the leading cause of prosthetic valve endocarditis, not native valve disease.

Angiotensin-converting enzyme inhibitors are the preferred first-line antihypertensive agents in diabetic patients, particularly those with microalbuminuria, because they reduce intraglomerular pressure by dilating the efferent arteriole and have proven renoprotective effects beyond blood pressure control. This action slows progression of diabetic nephropathy by reducing proteinuria independent of the degree of blood pressure lowering. Current guidelines recommend ACE inhibitors or angiotensin receptor blockers as the preferred agents whenever a diabetic patient has hypertension with evidence of albuminuria. Serum potassium and creatinine should be monitored after starting therapy, but his current values are within acceptable limits to initiate treatment.

• B. Calcium channel blockers are effective antihypertensives but lack the specific renoprotective effect on diabetic nephropathy seen with ACE inhibitors.
• C. Thiazides can worsen glycemic control and are not preferred as first-line therapy in diabetics with nephropathy.
• D. Beta-blockers can mask hypoglycemic symptoms and are not first-line in uncomplicated diabetic hypertension with albuminuria.

The standard first-line regimen under the National TB Elimination Programme (NTEP) for a new, rifampicin-sensitive case of pulmonary tuberculosis is a 2-month intensive phase with isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by a 4-month continuation phase with isoniazid and rifampicin. This daily regimen has replaced the earlier intermittent thrice-weekly DOTS regimen. Streptomycin is reserved for retreatment or drug-resistant cases, not first-line new cases. Dropping pyrazinamide and ethambutol in the intensive phase is inadequate and increases relapse and resistance risk.

• A. Streptomycin is added for retreatment or drug-resistant cases, not included in the standard first-line regimen for new cases.
• B. Using only two drugs without the initial intensive four-drug phase is inadequate for a new case of pulmonary TB and risks treatment failure and resistance.
• D. Continuing ethambutol instead of rifampicin in the continuation phase is not the standard regimen and is less effective for relapse prevention.

Isoniazid causes peripheral neuropathy by increasing the renal excretion of pyridoxine (vitamin B6) and inhibiting pyridoxal phosphate-dependent enzyme reactions needed for neurotransmitter and myelin synthesis. Co-administration of pyridoxine, typically 10 mg daily, prevents this adverse effect and is routinely given to patients at higher risk, such as those who are malnourished, pregnant, diabetic, or alcoholic. Folic acid, thiamine, and cyanocobalamin do not counteract isoniazid-induced pyridoxine deficiency.

• A. Thiamine deficiency causes beriberi and Wernicke's encephalopathy, not isoniazid-induced neuropathy.
• B. Cyanocobalamin deficiency causes subacute combined degeneration, unrelated to the mechanism of isoniazid toxicity.
• C. Folic acid deficiency is not the mechanism of isoniazid-induced neuropathy and does not prevent this adverse effect.

The diagnosis of COPD is confirmed spirometrically by a post-bronchodilator FEV1/FVC ratio of less than 0.70, indicating persistent airflow limitation that is not fully reversible, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). This patient's post-bronchodilator ratio of 0.65 meets this criterion. Pre-bronchodilator measurements are not used for diagnostic confirmation since airway obstruction must be assessed after bronchodilation. Significant FEV1 reversibility (>12% and 200 mL) is suggestive of asthma rather than fixed COPD. Elevated total lung capacity reflects hyperinflation and may support COPD but is not the diagnostic criterion.

• A. Marked reversibility of FEV1 after bronchodilator is characteristic of asthma, not fixed airflow obstruction of COPD.
• C. Increased total lung capacity indicates hyperinflation, which supports but does not define or confirm the diagnosis of COPD.
• D. Pre-bronchodilator values can be falsely low due to reversible bronchospasm and are not used for diagnostic confirmation of COPD.

In acute severe asthma with a silent chest, a life-threatening feature, the immediate management includes high-dose nebulized short-acting beta-2 agonist (salbutamol) combined with an anticholinergic (ipratropium) for bronchodilation, along with systemic corticosteroids such as intravenous hydrocortisone to reduce airway inflammation, given alongside high-flow oxygen. Oral montelukast and inhaled budesonide are maintenance therapies with too slow an onset for an acute severe attack. Intravenous aminophylline is not recommended as first-line due to a narrow therapeutic index and lack of added benefit over standard therapy. Subcutaneous terbutaline alone does not address airway inflammation and is not the preferred route when nebulization is available.

• A. Aminophylline alone is not first-line due to its narrow therapeutic index and lacks the rapid combined bronchodilator and anti-inflammatory effect needed.
• B. Montelukast and inhaled budesonide are controller medications with delayed onset of action, unsuitable for acute severe exacerbation.
• D. Subcutaneous terbutaline alone does not provide anti-inflammatory coverage and is reserved for situations where nebulization is not feasible.

The clinical picture of hypotension, tracheal deviation away from the affected side, hyperresonance, and absent breath sounds is classic for tension pneumothorax, a clinical diagnosis requiring immediate treatment without waiting for imaging. The immediate life-saving step is needle decompression, typically at the second intercostal space in the midclavicular line on the affected side, to relieve the pressure and restore venous return and cardiac output. This is followed by definitive tube thoracostomy. Delaying treatment for imaging in a hemodynamically unstable patient can be fatal.

• A. Fluids and vasopressors do not address the underlying mechanical cause of obstructive shock.
• C. Imaging delays life-saving treatment in a patient with a clinical diagnosis of tension pneumothorax.
• D. CT thorax is too time-consuming and unnecessary in an unstable patient with a clear clinical diagnosis.

Standard first-line triple therapy for H. pylori eradication consists of a proton pump inhibitor (such as omeprazole) combined with two antibiotics, amoxicillin and clarithromycin, given for 10-14 days. The PPI raises intragastric pH, which improves antibiotic stability and efficacy while also promoting ulcer healing. Amoxicillin inhibits bacterial cell wall synthesis, and clarithromycin inhibits bacterial protein synthesis, together achieving high eradication rates in clarithromycin-sensitive regions. In patients with penicillin allergy, metronidazole is substituted for amoxicillin.

• A. This fluoroquinolone-based combination is reserved for second-line or rescue therapy, not first-line treatment.
• C. Sucralfate is a mucosal protective agent, not an acid suppressant, and this is not a standard eradication regimen.
• D. Ranitidine is a weaker acid suppressant than a PPI and this combination is not a standard eradication regimen.

HBsAg (hepatitis B surface antigen) is the marker that directly reflects the presence of circulating viral particles and indicates current infection and infectivity, whether acute or chronic. Anti-HBc IgM indicates recent infection within the past six months but does not itself denote infectivity; it is a marker of the timing of infection. Anti-HBs indicates immunity, either from past infection or vaccination, and its presence with HBsAg clearance signals resolution. Anti-HBc IgG indicates past or chronic infection but, like IgM, reflects host antibody response rather than viral presence.

• B. Anti-HBc IgG indicates past exposure or chronic infection but does not directly indicate current infectivity.
• C. Anti-HBs indicates immunity and is typically absent during active infection.
• D. Anti-HBc IgM indicates recent infection timing but does not itself reflect ongoing viral presence.

Asterixis (flapping tremor) combined with altered sensorium in a patient with cirrhosis is characteristic of hepatic encephalopathy, caused by accumulation of ammonia and other gut-derived neurotoxins due to impaired hepatic clearance and portosystemic shunting. Constipation is a common precipitating factor, as it increases ammonia absorption from the gut. Management includes lactulose, which reduces colonic ammonia absorption, and identification and correction of precipitating factors. Hepatorenal syndrome presents with renal failure rather than asterixis, and spontaneous bacterial peritonitis typically presents with fever and abdominal pain.

• A. Hepatorenal syndrome presents with progressive renal failure, not primarily with asterixis and confusion.
• C. Wernicke's encephalopathy presents with ophthalmoplegia, ataxia, and confusion, not classically with asterixis.
• D. Spontaneous bacterial peritonitis typically presents with fever and abdominal pain, and diagnosis requires ascitic fluid analysis.

Serum lipase is more specific than amylase for diagnosing acute pancreatitis because it remains elevated for a longer duration and is less affected by other conditions such as salivary gland disease or renal failure. While amylase rises early and is commonly used, lipase has greater diagnostic sensitivity and specificity and is incorporated into modern diagnostic criteria. Although the classic Ranson's criteria historically used variables like glucose, LDH, and AST rather than lipase itself, lipase is now the preferred biochemical test for diagnosis in current practice. Diagnosis requires two of three criteria: characteristic abdominal pain, lipase or amylase more than three times the upper limit of normal, and characteristic imaging findings.

• A. Alkaline phosphatase reflects biliary obstruction or bone disease, not pancreatic acinar injury.
• B. Serum amylase is widely used but is less specific than lipase and returns to normal more quickly.
• C. Lactate dehydrogenase is a nonspecific marker of tissue injury used in prognostic scoring, not as the primary diagnostic enzyme.

Non-selective beta-blockers such as propranolol are first-line therapy for primary prophylaxis against variceal bleeding in patients with medium to large esophageal varices. They reduce portal pressure by decreasing cardiac output through beta-1 blockade and causing splanchnic vasoconstriction through unopposed alpha-adrenergic activity via beta-2 blockade, which reduces portal venous inflow. This lowers the hepatic venous pressure gradient and the risk of variceal rupture. Octreotide and terlipressin are used for acute variceal bleeding episodes, not for primary prevention.

• A. Furosemide is a diuretic used for ascites management and does not reduce portal pressure to prevent variceal bleeding.
• C. Octreotide is used for acute control of active variceal bleeding, not for primary prophylaxis.
• D. Terlipressin is used in acute variceal hemorrhage to reduce splanchnic blood flow, not for long-term prophylaxis.

Ulcerative colitis characteristically involves the rectum and extends proximally in a continuous fashion, with inflammation limited to the mucosa and submucosa, and the absence of granulomas. Crohn's disease, in contrast, can affect any part of the gastrointestinal tract from mouth to anus, shows skip lesions with intervening normal mucosa, causes transmural inflammation that can lead to fistulas and strictures, and often demonstrates non-caseating granulomas on histology. Recognizing the pattern of continuous, mucosa-limited, rectum-based involvement without granulomas is key to distinguishing ulcerative colitis from Crohn's disease. This distinction guides differences in medical and surgical management between the two conditions.

• B. Transmural inflammation with skip lesions is characteristic of Crohn's disease, not ulcerative colitis.
• C. Perianal fistulas are a hallmark of transmural Crohn's disease, not ulcerative colitis.
• D. Non-caseating granulomas are a histological feature of Crohn's disease, not ulcerative colitis.

In prerenal azotemia, renal tubular function is preserved and the kidney avidly reabsorbs sodium and water in response to hypoperfusion, producing a fractional excretion of sodium (FENa) below 1% and concentrated urine with high osmolality. This patient's hypotension, tachycardia, low urine sodium, and high urine osmolality all point to volume depletion from gastrointestinal losses causing prerenal AKI. FENa calculation compares sodium and creatinine clearance and is the key bedside test to distinguish prerenal from intrinsic renal causes such as acute tubular necrosis.

• A. Muddy brown casts indicate acute tubular necrosis, an intrinsic renal cause, not the prerenal picture suggested by this patient's findings
• B. A FENa above 2% suggests tubular dysfunction as in acute tubular necrosis, which is inconsistent with this patient's low urine sodium and concentrated urine
• C. A low specific gravity indicates dilute urine from impaired concentrating ability, the opposite of what is expected in prerenal AKI

Minimal change disease is the most common cause of nephrotic syndrome in children, accounting for over 80% of cases in those under 6 years. Light microscopy appears normal, and electron microscopy reveals diffuse effacement of podocyte foot processes. These children typically respond well to corticosteroid therapy and the diagnosis is often made clinically without biopsy in typical presentations. The absence of hematuria and hypertension in this selective proteinuria picture supports minimal change disease over other glomerulopathies.

• A. Segmental sclerosis describes focal segmental glomerulosclerosis, which is more common in older children and often steroid-resistant
• B. This describes a proliferative pattern seen in conditions like mesangiocapillary glomerulonephritis, which is less common in this age group and usually presents with hematuria
• D. A spike and dome appearance on electron microscopy is characteristic of membranous nephropathy, which is rare in young children

Uremic pericarditis, suggested by the positional chest pain and pericardial friction rub in a patient with advanced chronic kidney disease, is an absolute indication for urgent dialysis because of the risk of hemorrhagic pericardial effusion and tamponade. Other absolute indications include refractory fluid overload with pulmonary edema, severe hyperkalemia unresponsive to medical therapy, and uremic encephalopathy. Hemodialysis is preferred over peritoneal dialysis in this emergency setting because it corrects the metabolic derangement more rapidly. Diuretics and oral medical measures are inadequate for a uremic emergency of this severity.

• A. Oral medical measures do not adequately or rapidly treat uremic pericarditis, which requires emergent dialysis
• C. Peritoneal dialysis catheter placement takes time to mature and is too slow for this urgent presentation
• D. Diuretics alone will not address uremic pericarditis and may be ineffective given the severity of renal failure

Acute post-streptococcal glomerulonephritis classically follows a latent period of 1-3 weeks after streptococcal pharyngitis, presenting with the nephritic syndrome of hematuria, edema, and hypertension, along with transient hypocomplementemia due to immune complex deposition. The low C3 level that normalizes within 6-8 weeks is a key diagnostic feature distinguishing it from conditions with persistently low complement. This child's 2-week latency after sore throat fits the typical timeline for the post-streptococcal immune response rather than a direct infective process.

• B. IgA nephropathy typically presents with hematuria within 1-3 days of a respiratory infection (synpharyngitic), not after a latent period, and complement levels are usually normal
• C. Membranoproliferative glomerulonephritis causes persistently low complement levels lasting beyond 8 weeks, unlike the transient hypocomplementemia here
• D. Henoch-Schonlein purpura nephritis is accompanied by palpable purpura, arthralgia, and abdominal pain, none of which are described in this case

Calcium oxalate stones are the most common type of urinary calculi, accounting for the majority of cases, and classically produce envelope-shaped or dumbbell-shaped crystals on urine microscopy. They form due to hypercalciuria, hyperoxaluria, or hypocitraturia and appear radio-opaque on plain X-ray. Risk factors include low fluid intake, high dietary oxalate, and certain metabolic conditions. Most patients with calcium oxalate stones have idiopathic hypercalciuria as the underlying metabolic abnormality.

• A. Uric acid stones produce rhomboid or rosette-shaped crystals and occur in conditions of low urine pH such as gout, but are less common than calcium oxalate stones
• B. Cystine stones produce hexagonal crystals and occur in the inherited disorder cystinuria, which is rare compared to calcium oxalate stones
• D. Struvite stones form in the setting of urease-producing bacterial infections and produce coffin-lid shaped crystals, and are less common overall

The diagnosis of diabetes mellitus can be established by a fasting plasma glucose of 126 mg/dL or higher on two separate occasions, according to American Diabetes Association criteria adopted widely in Indian practice. Other diagnostic criteria include a 2-hour plasma glucose of 200 mg/dL or higher during a 75 g oral glucose tolerance test, HbA1c of 6.5% or higher, or a random plasma glucose of 200 mg/dL or higher with classic symptoms of hyperglycemia. This patient's two fasting values above the 126 mg/dL threshold are sufficient to confirm the diagnosis without needing further testing.

• A. An oral glucose tolerance test is not mandatory once the diagnosis is already confirmed by two fasting values meeting the diagnostic threshold
• B. A random glucose criterion requires symptoms of hyperglycemia along with the elevated value; it is not the only pathway to diagnosis when fasting criteria are already met
• C. Impaired fasting glucose refers to fasting levels of 100-125 mg/dL, which is lower than this patient's confirmed values above 126 mg/dL

The first priority in managing diabetic ketoacidosis is aggressive fluid resuscitation with isotonic saline to correct hypovolemia and improve tissue perfusion, especially in a hypotensive patient with hemodynamic compromise. Fluid replacement alone lowers blood glucose by improving renal perfusion and dilution, and must precede or accompany insulin therapy, since starting insulin before adequate fluid resuscitation risks worsening hypotension and precipitating cardiovascular collapse. Insulin infusion is started after initial fluid resuscitation has begun, and potassium levels must be checked and corrected before or during insulin therapy to prevent hypokalemia. Bicarbonate is reserved for severe acidosis with pH below 6.9 and is not a first-line step in this setting.

• A. Bicarbonate is not routinely used in DKA management and is reserved for extreme acidosis below pH 6.9, not as the initial step here
• C. Potassium should not be given empirically first; initial fluids and reassessment of serum potassium take priority before potassium replacement decisions
• D. Insulin should follow initiation of fluid resuscitation, since giving insulin first in a hypotensive patient can worsen hypotension by driving potassium and water into cells

Metformin activates AMP-activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and glycogenolysis while improving insulin sensitivity in skeletal muscle and adipose tissue, increasing peripheral glucose uptake. It does not stimulate insulin secretion, so it does not cause hypoglycemia when used alone. This insulin-independent action makes it the preferred first-line agent in type 2 diabetes, especially in obese patients. It also has weight-neutral or mild weight-reducing effects compared with insulin secretagogues.

• A. This describes alpha-glucosidase inhibitors such as acarbose.
• B. This describes SGLT2 inhibitors such as empagliflozin.
• C. This describes sulfonylureas, which act on pancreatic beta cells via the SUR1 receptor.

Serum TSH is the single best initial test for suspected thyroid dysfunction because it is the most sensitive marker of primary thyroid disease, rising before free T4 falls in early primary hypothyroidism. The clinical picture of fatigue, weight gain, and a diffuse firm goiter in a young woman is classic for Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient areas. If TSH is elevated, free T4 is then checked to assess severity, and anti-TPO antibodies confirm autoimmune etiology. Imaging is not required for the initial diagnosis of hypothyroidism.

• A. Free T4 is checked after TSH confirms thyroid dysfunction, not as the first screening test.
• B. Ultrasonography assesses gland structure and nodules but does not assess thyroid function.
• C. Anti-TPO antibodies confirm Hashimoto's thyroiditis as the cause but do not establish the diagnosis of hypothyroidism itself.

Graves' disease is an autoimmune disorder caused by thyroid-stimulating immunoglobulins (TSIs) that bind to and activate the TSH receptor on follicular cells, mimicking TSH action and driving continuous, unregulated synthesis and release of thyroid hormone. This explains the diffuse goiter, suppressed TSH due to negative feedback, and extrathyroidal manifestations like ophthalmopathy from retro-orbital tissue involvement. The clinical triad of goiter, exophthalmos, and hyperthyroid symptoms in a young woman is classic. Antibody-mediated receptor activation distinguishes Graves' disease from other causes of thyrotoxicosis.

• A. This describes subacute (de Quervain) thyroiditis, which causes transient thyrotoxicosis without TSH receptor antibodies.
• B. A TSH-secreting pituitary adenoma would show elevated, not suppressed, TSH.
• C. This describes toxic adenoma, which does not typically cause ophthalmopathy or a diffuse goiter.

In Cushing's disease, a pituitary corticotroph adenoma retains partial sensitivity to negative feedback, so high-dose dexamethasone (which produces supraphysiologic glucocorticoid levels) suppresses cortisol by more than 50%, while low-dose dexamethasone fails to suppress it. Elevated ACTH confirms an ACTH-dependent cause, ruling out adrenal and exogenous sources. Ectopic ACTH-secreting tumors are typically autonomous and do not suppress even with high-dose dexamethasone. This stepwise testing pattern is the classic method to localize the source of hypercortisolism.

• A. Exogenous steroid use suppresses endogenous ACTH, which would be low, not elevated.
• B. Adrenal adenomas are ACTH-independent and would show a suppressed, not elevated, ACTH level.
• C. Ectopic ACTH sources are usually resistant to suppression even with high-dose dexamethasone.

Iron deficiency anemia is characterized by depleted iron stores, so serum ferritin, the body's iron storage marker, is low. Serum iron is also low because less iron is available for transport. Total iron-binding capacity (TIBC) rises as a compensatory response, with increased transferrin production to maximize capture of the scarce circulating iron. This combination, along with microcytic hypochromic red cells on smear, is the classic laboratory pattern of iron deficiency anemia, distinguishing it from anemia of chronic disease where ferritin is normal or high with low TIBC.

• B. High serum iron and ferritin suggest iron overload states, not deficiency.
• C. High ferritin with low TIBC is seen in anemia of chronic disease, not iron deficiency.
• D. Normal serum iron and high ferritin with normal TIBC do not fit iron deficiency anemia.

Hemophilia A results from deficiency of factor VIII, a component of the intrinsic coagulation pathway, which is screened by aPTT. The PT, which reflects the extrinsic pathway, remains normal since factors VII, X, V, II, and fibrinogen are unaffected. Platelet count and bleeding time are normal because platelet function is not impaired. The gene for factor VIII is located on the X chromosome, so the disease is X-linked recessive, explaining why only the maternal uncle (not the mother) is affected.

• A. aPTT is markedly prolonged, not normal, as factor VIII is part of the intrinsic pathway; bleeding time is normal since platelets are unaffected.
• B. Hemophilia A is X-linked recessive, not autosomal dominant, and aPTT rather than PT is prolonged.
• C. Hemophilia A is X-linked, not autosomal, and PT remains normal since the extrinsic pathway is unaffected.

Immune thrombocytopenic purpura is caused by autoantibodies, typically IgG, directed against platelet surface glycoproteins such as GPIIb/IIIa. Antibody-coated platelets are recognized and destroyed by Fc receptor-bearing macrophages in the spleen, leading to peripheral destruction despite normal or increased platelet production. This explains the compensatory increase in megakaryocytes seen on bone marrow examination, with normal maturation, and the absence of splenomegaly, which distinguishes ITP from other causes of thrombocytopenia. A preceding viral illness is a common trigger in acute ITP, especially in children and young adults.

• A. Microthrombi formation with consumption is characteristic of thrombotic thrombocytopenic purpura or DIC, not ITP, and would show schistocytes on smear.
• B. Bone marrow shows increased, not decreased, megakaryocytes in ITP, ruling out a production defect.
• C. ITP characteristically does not cause splenomegaly, distinguishing it from hypersplenism-related sequestration.

The clinical picture of fever, chills, flank pain, hypotension, and hemoglobinuria shortly after starting a transfusion indicates an acute hemolytic transfusion reaction, usually from ABO incompatibility causing complement-mediated intravascular hemolysis. The first and most critical step is to stop the transfusion immediately to prevent further infusion of incompatible blood. Intravenous fluids are then given to maintain urine output and renal perfusion, as acute kidney injury from hemoglobin-induced tubular damage is the major life-threatening complication. The blood bag should be sent back for repeat cross-matching and the patient's blood tested for hemolysis and direct antiglobulin test.

• B. Slowing the transfusion is inadequate; any suspected hemolytic reaction mandates immediate cessation, not continuation at a reduced rate.
• C. Corticosteroids have no established role in acute hemolytic transfusion reaction, and continuing the transfusion would worsen hemolysis.
• D. A new unit from the same donor does not address the incompatibility problem and risks repeating the reaction; the transfusion must be stopped and the cause investigated first.

The sickling solubility test, which relies on the reduced solubility of deoxygenated hemoglobin S causing turbidity in a reducing solution, is a rapid and inexpensive screening test used in community and hospital settings. It cannot distinguish sickle cell trait from sickle cell disease or identify other hemoglobin variants, so a positive result must be confirmed by hemoglobin electrophoresis, which separates hemoglobin fractions and quantifies HbS, HbF, and HbA2. This two-step approach is standard practice in India given the high prevalence of sickle cell disease in tribal populations. Electrophoresis also helps detect compound heterozygous states such as HbS-beta thalassemia.

• A. The order is reversed; electrophoresis is the confirmatory test, while the solubility test is used for initial screening.
• C. Osmotic fragility test screens for hereditary spherocytosis, not sickle cell disease, and bone marrow biopsy is not used for diagnosis.
• D. The Coombs test detects immune-mediated hemolysis and antibody coating of red cells, not hemoglobin variants.

The National Vector Borne Disease Control Programme (now National Center for Vector Borne Diseases Control) recommends artemisinin-based combination therapy with artesunate plus sulfadoxine-pyrimethamine for 3 days as first-line treatment for uncomplicated P. falciparum malaria in India, combined with a single dose of primaquine for its gametocytocidal effect to reduce transmission. Chloroquine is no longer effective against P. falciparum in most parts of India due to widespread resistance, though it remains the drug of choice for P. vivax. Intravenous artesunate is reserved for severe or complicated malaria, not uncomplicated cases with normal sensorium and organ function. Quinine-based regimens are alternatives used mainly in artemisinin resistance areas or when ACT is contraindicated.

• B. Chloroquine is ineffective against P. falciparum due to resistance in India; this regimen is used for P. vivax infection.
• C. Intravenous artesunate is indicated only for severe or complicated malaria, not for this uncomplicated case.
• D. Quinine plus doxycycline is not the first-line regimen under the national program and is reserved for specific circumstances such as pregnancy or treatment failure.

Persistent vomiting, severe abdominal pain, and a rising hematocrit concurrent with falling platelet count during defervescence are warning signs per WHO criteria that indicate increased vascular permeability and plasma leakage, signaling possible progression to severe dengue. These patients require close monitoring with serial hematocrit and vital signs, as they are at risk of developing dengue shock syndrome within the critical phase, typically around the time of defervescence. The rising hematocrit reflects plasma leakage before hypotension develops, making it an earlier marker than frank shock. Early recognition allows timely fluid management to prevent progression to shock.

• B. There are no neurological findings such as altered sensorium, seizures, or focal deficits to suggest encephalitis.
• C. This is not the benign resolving course; new abdominal pain, vomiting, and hemoconcentration signal a complication requiring vigilance, not simple recovery.
• D. Dengue shock syndrome requires frank hypotension or narrow pulse pressure with signs of poor perfusion, which are not yet present here.

NACO's strategy for HIV diagnosis requires three different antigen/antibody-based rapid test kits to be used in series, each with differing antigen compositions or principles, to minimize false positives. A sample reactive on the first test must be tested with a second, different kit; if both are reactive, a third different kit is used before a positive diagnosis is reported. Using the same kit twice does not reduce the risk of a shared false-positive cause. Viral load testing is used for monitoring, not initial diagnosis.

• A. Repeating the identical kit does not rule out a false positive caused by the same cross-reacting antigen.
• C. A single reactive test is insufficient; the diagnosis requires concordance on three different test kits per NACO strategy.
• D. Viral load/RNA testing is not the standard initial diagnostic tool in the ICTC algorithm; it is used for monitoring or early infant diagnosis.

Leptospirosis is an occupational zoonosis affecting farmers, sewage workers, and those exposed to water contaminated with rodent urine, caused by Leptospira interrogans. For mild to moderate disease without severe organ involvement, oral doxycycline is the drug of choice; it also eradicates the renal carrier state. Severe disease with jaundice or renal failure (Weil's disease) requires intravenous penicillin G or ceftriaxone instead. Fluoroquinolones, metronidazole, and antimalarials have no established role in leptospirosis treatment.

• A. Chloroquine is an antimalarial with no role in the treatment of leptospirosis.
• B. Ciprofloxacin is not a standard agent for leptospirosis; it is used for other bacterial infections such as typhoid or UTI.
• C. Metronidazole targets anaerobes and protozoa and has no activity against Leptospira.

The quick SOFA (qSOFA) score uses three bedside criteria: respiratory rate ≥22/min, systolic blood pressure ≤100 mmHg, and altered mentation (GCS <15). A score of 2 or more identifies patients with suspected infection who are at high risk of poor outcomes and need prompt evaluation for sepsis and organ dysfunction. This patient meets all three criteria, giving a qSOFA of 3, which mandates escalation of care, further workup including lactate and blood cultures, and consideration of ICU-level monitoring. Discharge or routine ward observation would delay recognition of life-threatening sepsis.

• B. A high qSOFA score indicates high risk and is inappropriate for discharge.
• C. Routine ward care with delayed reassessment does not match the urgency indicated by a high qSOFA score.
• D. A chest X-ray may be part of workup but is not the priority step; escalation and sepsis evaluation take precedence.

Intravenous alteplase is indicated in acute ischemic stroke when given within 4.5 hours of clearly defined symptom onset, after hemorrhage has been excluded by non-contrast CT and other contraindications have been ruled out. This patient is within the window at 2 hours, has a CT confirming no bleed, and has a controlled blood pressure below the 185/110 mmHg threshold, making him an ideal candidate for thrombolysis. Dual antiplatelet therapy is used for minor stroke or TIA without thrombolysis, not as an alternative to alteplase in an eligible candidate. Mechanical thrombectomy is generally reserved for large vessel occlusion and can be combined with, not substituted for, thrombolysis when alteplase is eligible.

• B. Dual antiplatelet therapy is not the primary treatment when the patient qualifies for thrombolysis within the window.
• C. Delaying treatment risks loss of salvageable brain tissue; thrombolysis should be given promptly within the window, not after further observation.
• D. Thrombectomy does not replace thrombolysis in an eligible patient within the alteplase window; both may be used together if large vessel occlusion is confirmed.

Status epilepticus is defined as a seizure lasting more than 5 minutes or recurrent seizures without recovery of consciousness between them, and it is a medical emergency. Intravenous benzodiazepines, with lorazepam preferred over diazepam for its longer duration of anti-seizure action, are the first-line agents to terminate the seizure rapidly by enhancing GABA-mediated inhibition. If seizures persist after benzodiazepines, a second-line agent such as intravenous phenytoin, valproate, or levetiracetam is used for sustained control. Phenobarbitone is generally reserved for refractory status epilepticus after first- and second-line agents have failed.

• A. Phenytoin is a second-line agent used after benzodiazepines have been given, not the initial drug of choice.
• B. Levetiracetam is used as a second-line agent for sustained seizure control, not as the first drug to terminate an ongoing seizure.
• C. Phenobarbitone is reserved for refractory status epilepticus unresponsive to first- and second-line therapy.

Myasthenia gravis is an autoimmune disorder in which antibodies target postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, reducing the number of functional receptors and impairing neuromuscular transmission. This produces fatigable weakness that worsens with sustained activity, classically affecting ocular, bulbar, and proximal limb muscles. The edrophonium (Tensilon) test, an acetylcholinesterase inhibitor, transiently increases acetylcholine availability at the synapse and produces rapid, short-lived improvement in weakness, supporting the diagnosis, which is confirmed by detecting anti-acetylcholine receptor antibodies. Antibodies against presynaptic calcium channels instead cause Lambert-Eaton myasthenic syndrome, which improves with repeated use rather than worsening.

• A. Demyelination describes disorders like Guillain-Barré syndrome, not the autoimmune neuromuscular junction defect of myasthenia gravis.
• B. This describes Lambert-Eaton myasthenic syndrome, which presents with proximal weakness that improves with repeated muscle use, not fatigable weakness like myasthenia gravis.
• D. Antibodies against acetylcholinesterase itself are not the mechanism of myasthenia gravis; the target is the acetylcholine receptor.

Guillain-Barré syndrome classically shows albuminocytological dissociation: markedly raised CSF protein due to inflammation and increased permeability of nerve roots, with a normal or only mildly elevated cell count (usually under 10 cells/mm3, lymphocytic). This finding typically appears after the first week of symptoms and helps distinguish GBS from infective causes of acute weakness. The protein rise reflects damage to nerve root sheaths rather than meningeal inflammation, so pleocytosis is characteristically absent.

• A. Lymphocytic pleocytosis with only mild protein rise is typical of viral meningitis, not GBS.
• B. Marked neutrophilic pleocytosis with raised protein points to bacterial infection, not a demyelinating polyradiculoneuropathy.
• D. High neutrophilic pleocytosis with near-normal protein suggests bacterial meningitis, not GBS.

Parkinson's disease results from progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced dopamine input to the striatum and disruption of the basal ganglia motor circuit. This produces the cardinal features of bradykinesia, resting tremor, rigidity, and postural instability. Lewy bodies, intracytoplasmic alpha-synuclein inclusions, are the characteristic pathological hallmark found in surviving neurons. Dopamine replacement with levodopa forms the mainstay of symptomatic treatment because it compensates for this striatal dopamine deficiency.

• A. Nucleus basalis of Meynert cholinergic loss is associated with Alzheimer's disease, not Parkinson's disease.
• C. Anterior horn cell degeneration causes lower motor neuron weakness as seen in motor neuron disease, not parkinsonism.
• D. Corticospinal tract demyelination causes upper motor neuron signs such as spasticity and hyperreflexia, not parkinsonian features.

The clinical pattern of symmetric small joint polyarthritis involving the MCP and PIP joints with DIP sparing and prolonged morning stiffness is classic for rheumatoid arthritis. Anti-CCP antibody has high specificity (around 95%) for rheumatoid arthritis and can appear years before clinical onset, making it the most specific serological marker. Rheumatoid factor is more sensitive but less specific, as it is also positive in other conditions such as Sjögren syndrome, hepatitis C, and chronic infections. Anti-CCP positivity is also associated with more erosive and severe disease.

• A. Rheumatoid factor is sensitive for rheumatoid arthritis but less specific, being positive in several other rheumatologic and infectious conditions.
• B. Anti-Smith antibody is highly specific for systemic lupus erythematosus, not rheumatoid arthritis.
• C. Antinuclear antibody is a sensitive screening test for SLE, not specific for rheumatoid arthritis.

Antinuclear antibody (ANA) is present in over 95% of patients with systemic lupus erythematosus, making it an excellent initial screening test due to its high sensitivity, although it lacks specificity since it is positive in many other autoimmune conditions. Anti-double-stranded DNA antibody, while less sensitive, is highly specific for SLE and its titers correlate with disease activity, particularly lupus nephritis. The standard diagnostic approach therefore is to screen with ANA and confirm with anti-dsDNA in a patient with a compatible clinical picture. This two-step approach avoids both missing true cases and over-diagnosing based on a nonspecific positive ANA alone.

• B. This reverses the correct order; anti-dsDNA is far less sensitive than ANA and is not used as a first-line screening test.
• C. Anti-Ro and anti-La antibodies are associated with Sjögren syndrome and neonatal lupus, not the primary screening and confirmatory tests for SLE.
• D. Rheumatoid factor is not a screening test for SLE, and anti-Smith, though specific, is less commonly used for confirmation than anti-dsDNA.

This presentation is classic for acute gouty arthritis caused by deposition of monosodium urate crystals in the joint, triggering an acute inflammatory response mediated by NLRP3 inflammasome activation and neutrophil recruitment. Colchicine works by inhibiting microtubule polymerization in neutrophils, reducing their migration and phagocytic activity, thereby controlling the acute inflammatory attack. Urate-lowering agents such as allopurinol, febuxostat, and probenecid are used for long-term control of hyperuricemia and are not started during an acute flare because they can transiently worsen the attack by mobilizing urate crystals. Acute management focuses on anti-inflammatory therapy, with NSAIDs, colchicine, or corticosteroids as first-line options.

• A. Allopurinol is a xanthine oxidase inhibitor used for chronic urate-lowering therapy, not for treating an acute attack, and starting it during a flare can worsen symptoms.
• C. Probenecid is a uricosuric agent for chronic management and is not used to treat acute gout.
• D. Febuxostat is a xanthine oxidase inhibitor used for long-term urate lowering, not for acute attacks.

Osteoarthritis is a degenerative joint disease characterized radiographically by asymmetric loss of joint space (typically in the weight-bearing compartment), osteophyte formation at joint margins, subchondral sclerosis, and sometimes subchondral cysts. These changes reflect mechanical wear, cartilage breakdown, and reactive bone remodeling rather than an inflammatory process. The clinical picture of activity-related pain with brief morning stiffness is also typical of osteoarthritis, contrasting with the prolonged stiffness seen in inflammatory arthritides. This combination of clinical and radiographic features is used to clinically diagnose osteoarthritis without need for further serological testing.

• A. Diffuse joint space narrowing with cartilage calcification (chondrocalcinosis) suggests calcium pyrophosphate deposition disease (pseudogout).
• B. Punched-out lytic lesions with overhanging edges are the classic tophus-related finding in chronic gout.
• C. Symmetric joint space loss with periarticular osteopenia and marginal erosions is characteristic of rheumatoid arthritis, an inflammatory arthropathy.

Organophosphorus compounds irreversibly inhibit acetylcholinesterase, causing accumulation of acetylcholine at both muscarinic and nicotinic receptor sites, producing the classic cholinergic toxidrome of salivation, lacrimation, miosis, bradycardia, bronchorrhea, and fasciculations. Atropine is the immediate first-line antidote because it competitively blocks muscarinic receptors, reversing the life-threatening bradycardia, bronchospasm, and secretions, and is titrated to drying of secretions and heart rate improvement. Pralidoxime is given alongside atropine to reactivate acetylcholinesterase at nicotinic sites and improve muscle weakness and fasciculations, but it does not act as rapidly on the muscarinic symptoms as atropine does. Neostigmine and physostigmine are themselves acetylcholinesterase inhibitors and would worsen cholinergic toxicity, so they have no role in management.

• A. Neostigmine further inhibits acetylcholinesterase and would worsen the cholinergic crisis.
• B. Pralidoxime is an important adjunct that reactivates acetylcholinesterase but is not the first drug given and acts mainly on nicotinic symptoms.
• D. Physostigmine also inhibits acetylcholinesterase and would aggravate rather than treat organophosphorus toxicity.

Paracetamol is normally conjugated with glucuronide and sulfate, with a small fraction oxidized by CYP2E1 to the reactive metabolite NAPQI, which is detoxified by conjugation with glutathione. In overdose, glucuronide/sulfate pathways are saturated, more NAPQI is formed, and hepatic glutathione is depleted, allowing NAPQI to bind hepatocyte macromolecules and cause necrosis. N-acetylcysteine acts as a glutathione precursor and substitute, replenishing glutathione stores and providing an alternative substrate for NAPQI conjugation, preventing hepatotoxicity. It is most effective when given within 8-10 hours of ingestion but has benefit even later.

• A. N-acetylcysteine does not directly chelate NAPQI; it acts by restoring glutathione.
• C. N-acetylcysteine does not act primarily by increasing renal excretion of the parent drug.
• D. N-acetylcysteine does not act by inhibiting CYP2E1; that mechanism describes drugs like cimetidine, which are not first-line.

The 20-minute whole blood clotting test (20WBCT) is a simple bedside tool to detect venom-induced consumption coagulopathy, which is characteristic of hemotoxic (vasculotoxic) snakes such as Russell's viper and saw-scaled viper. Venom procoagulant enzymes activate the clotting cascade, rapidly depleting fibrinogen and clotting factors, so that blood drawn into a clean glass tube and left undisturbed for 20 minutes fails to form a stable clot. A positive (non-clotting) 20WBCT confirms systemic envenomation by a hemotoxic species and is used to guide the decision to start anti-snake venom. Neurotoxic envenomation from elapids such as cobra and krait typically does not affect clotting, so the test remains normal in those cases.

• A. Neurotoxic envenomation does not impair clotting, so the test would show a normal clot, not failure to clot.
• B. Failure to clot reflects coagulopathy, not neuromuscular blockade, and anticholinesterases are used for neurotoxic signs, not this finding.
• C. A non-envenomed or dry bite would show a normal clot within 20 minutes, not failure to clot.